| negative regulation of viral genome replication | GO:0045071 | 10 | 0.963 | |
| activation of innate immune response | GO:0002218 | 56 | 0.952 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.906 | |
| symbiosis encompassing mutualism through parasitism | GO:0044403 | 83 | 0.845 | |
| defense response to virus | GO:0051607 | 68 | 0.813 | |
| regulation of symbiosis encompassing mutualism through parasitism | GO:0043903 | 52 | 0.770 | |
| immune effector process | GO:0002252 | 321 | 0.725 | |
| defense response to other organism | GO:0098542 | 197 | 0.666 | |
| viral process | GO:0016032 | 41 | 0.610 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.589 | |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.469 | |
| cellular nitrogen compound catabolic process | GO:0044270 | 280 | 0.469 | |
| defense response to protozoan | GO:0042832 | 25 | 0.421 | |
| nucleoside phosphate metabolic process | GO:0006753 | 338 | 0.408 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.408 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.400 | |
| heterocycle catabolic process | GO:0046700 | 280 | 0.385 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.378 | |
| viral genome replication | GO:0019079 | 17 | 0.362 | |
| negative regulation of viral process | GO:0048525 | 23 | 0.358 | |
| viral life cycle | GO:0019058 | 36 | 0.350 | |
| regulation of viral genome replication | GO:0045069 | 13 | 0.346 | |
| nucleobase containing small molecule metabolic process | GO:0055086 | 352 | 0.344 | |
| innate immune response activating signal transduction | GO:0002758 | 50 | 0.328 | |
| rig i signaling pathway | GO:0039529 | 4 | 0.298 | |
| innate immune response | GO:0045087 | 157 | 0.283 | |
| ribonucleoside catabolic process | GO:0042454 | 206 | 0.281 | |
| toll like receptor 7 signaling pathway | GO:0034154 | 4 | 0.278 | |
| regulation of innate immune response | GO:0045088 | 91 | 0.274 | |
| pattern recognition receptor signaling pathway | GO:0002221 | 47 | 0.271 | |
| regulation of defense response to virus by host | GO:0050691 | 8 | 0.262 | |
| leukocyte activation involved in immune response | GO:0002366 | 126 | 0.262 | |
| glycosyl compound catabolic process | GO:1901658 | 206 | 0.242 | |
| cytokine production | GO:0001816 | 319 | 0.239 | |
| nucleotide metabolic process | GO:0009117 | 332 | 0.235 | |
| regulation of interleukin 4 biosynthetic process | GO:0045402 | 3 | 0.227 | |
| purine containing compound metabolic process | GO:0072521 | 311 | 0.223 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.220 | |
| t helper 17 cell lineage commitment | GO:0072540 | 4 | 0.220 | |
| cytoplasmic pattern recognition receptor signaling pathway in response to virus | GO:0039528 | 4 | 0.216 | |
| glycosyl compound metabolic process | GO:1901657 | 246 | 0.207 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.199 | |
| purine nucleoside catabolic process | GO:0006152 | 205 | 0.180 | |
| purine nucleotide catabolic process | GO:0006195 | 211 | 0.175 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.172 | |
| cellular response to interferon alpha | GO:0035457 | 4 | 0.168 | |
| purine nucleotide metabolic process | GO:0006163 | 302 | 0.168 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.165 | |
| myoblast differentiation involved in skeletal muscle regeneration | GO:0014835 | 3 | 0.161 | |
| organonitrogen compound catabolic process | GO:1901565 | 264 | 0.152 | |
| regulation of multi organism process | GO:0043900 | 111 | 0.151 | |
| cellular response to interferon beta | GO:0035458 | 21 | 0.150 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.149 | |
| nucleoside triphosphate metabolic process | GO:0009141 | 230 | 0.146 | |
| rna catabolic process | GO:0006401 | 29 | 0.144 | |
| tumor necrosis factor production | GO:0032640 | 50 | 0.144 | |
| response to protozoan | GO:0001562 | 28 | 0.143 | |
| purine ribonucleoside triphosphate metabolic process | GO:0009205 | 220 | 0.139 | |
| cell activation involved in immune response | GO:0002263 | 126 | 0.138 | |
| purine nucleoside triphosphate metabolic process | GO:0009144 | 226 | 0.132 | |
| positive regulation of rig i signaling pathway | GO:1900246 | 1 | 0.132 | |
| organophosphate catabolic process | GO:0046434 | 232 | 0.132 | |
| purine ribonucleoside triphosphate catabolic process | GO:0009207 | 199 | 0.131 | |
| nucleoside phosphate catabolic process | GO:1901292 | 222 | 0.130 | |
| myeloid cell differentiation | GO:0030099 | 233 | 0.126 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.123 | |
| positive regulation of interferon alpha production | GO:0032727 | 4 | 0.120 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.119 | |
| viral gene expression | GO:0019080 | 3 | 0.119 | |
| purine ribonucleoside catabolic process | GO:0046130 | 205 | 0.118 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.115 | |
| dna recombination | GO:0006310 | 92 | 0.109 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.108 | |
| cellular response to lipopolysaccharide | GO:0071222 | 77 | 0.107 | |
| nucleoside phosphate biosynthetic process | GO:1901293 | 79 | 0.105 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.104 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.103 | |
| regulation of rig i signaling pathway | GO:0039535 | 2 | 0.103 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.102 | |
| ribose phosphate metabolic process | GO:0019693 | 291 | 0.102 | |
| t cell activation | GO:0042110 | 289 | 0.101 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.097 | |
| nucleoside triphosphate catabolic process | GO:0009143 | 205 | 0.096 | |
| t cell differentiation | GO:0030217 | 174 | 0.095 | |
| guanosine containing compound metabolic process | GO:1901068 | 144 | 0.095 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.092 | |
| lymphocyte differentiation | GO:0030098 | 242 | 0.091 | |
| alpha beta t cell differentiation involved in immune response | GO:0002293 | 30 | 0.091 | |
| purine ribonucleotide metabolic process | GO:0009150 | 290 | 0.090 | |
| adaptive immune response | GO:0002250 | 155 | 0.086 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.085 | |
| positive regulation of immune effector process | GO:0002699 | 107 | 0.085 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.084 | |
| carbohydrate derivative catabolic process | GO:1901136 | 231 | 0.084 | |
| response to dsrna | GO:0043331 | 30 | 0.082 | |
| purine ribonucleoside metabolic process | GO:0046128 | 241 | 0.081 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.081 | |
| somatic recombination of immunoglobulin genes involved in immune response | GO:0002204 | 36 | 0.079 | |
| t helper cell differentiation | GO:0042093 | 28 | 0.077 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.077 | |
| cd4 positive alpha beta t cell differentiation involved in immune response | GO:0002294 | 28 | 0.077 | |
| regulation of interferon beta production | GO:0032648 | 13 | 0.076 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.076 | |
| nucleoside metabolic process | GO:0009116 | 246 | 0.075 | |
| protein ubiquitination | GO:0016567 | 171 | 0.075 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.075 | |
| t cell differentiation involved in immune response | GO:0002292 | 30 | 0.075 | |
| protein oligomerization | GO:0051259 | 67 | 0.074 | |
| cellular response to lipid | GO:0071396 | 145 | 0.073 | |
| regulation of cell activation | GO:0050865 | 289 | 0.073 | |
| nucleotide biosynthetic process | GO:0009165 | 78 | 0.071 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.071 | |
| regulation of defense response | GO:0031347 | 233 | 0.071 | |
| viral transcription | GO:0019083 | 3 | 0.071 | |
| purine nucleoside triphosphate catabolic process | GO:0009146 | 203 | 0.070 | |
| toll like receptor signaling pathway | GO:0002224 | 38 | 0.070 | |
| response to interferon gamma | GO:0034341 | 34 | 0.070 | |
| stem cell differentiation | GO:0048863 | 268 | 0.069 | |
| regulation of defense response to virus | GO:0050688 | 18 | 0.069 | |
| nucleoside catabolic process | GO:0009164 | 206 | 0.067 | |
| ribonucleoside metabolic process | GO:0009119 | 245 | 0.066 | |
| positive regulation of viral genome replication | GO:0045070 | 2 | 0.065 | |
| isotype switching | GO:0045190 | 36 | 0.064 | |
| t cell selection | GO:0045058 | 34 | 0.062 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.062 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 36 | 0.062 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.062 | |
| cd8 positive alpha beta t cell proliferation | GO:0035740 | 1 | 0.062 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.062 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.062 | |
| negative regulation of nlrp3 inflammasome complex assembly | GO:1900226 | 2 | 0.061 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.060 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.060 | |
| signal transduction by p53 class mediator | GO:0072331 | 51 | 0.060 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.059 | |
| mda 5 signaling pathway | GO:0039530 | 1 | 0.059 | |
| ribonucleoside triphosphate catabolic process | GO:0009203 | 199 | 0.058 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.058 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.058 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.058 | |
| regulation of type i interferon production | GO:0032479 | 22 | 0.058 | |
| b cell activation | GO:0042113 | 161 | 0.057 | |
| rna interference | GO:0016246 | 2 | 0.057 | |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.057 | |
| nucleotide catabolic process | GO:0009166 | 217 | 0.057 | |
| type i interferon production | GO:0032606 | 29 | 0.057 | |
| chromatin organization | GO:0006325 | 206 | 0.056 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.055 | |
| interferon beta production | GO:0032608 | 16 | 0.055 | |
| negative regulation of cell development | GO:0010721 | 169 | 0.055 | |
| stem cell maintenance | GO:0019827 | 130 | 0.055 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.055 | |
| immunoglobulin production involved in immunoglobulin mediated immune response | GO:0002381 | 43 | 0.055 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.052 | |
| myeloid leukocyte differentiation | GO:0002573 | 119 | 0.052 | |
| t cell lineage commitment | GO:0002360 | 13 | 0.052 | |
| dna metabolic process | GO:0006259 | 303 | 0.051 | |
| regulation of schwann cell proliferation | GO:0010624 | 2 | 0.050 | |
| mapk cascade | GO:0000165 | 281 | 0.050 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.049 | |
| purine nucleotide biosynthetic process | GO:0006164 | 65 | 0.049 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.048 | |
| gene silencing | GO:0016458 | 38 | 0.048 | |
| regulation of toll like receptor signaling pathway | GO:0034121 | 20 | 0.047 | |
| purine nucleoside metabolic process | GO:0042278 | 241 | 0.047 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.046 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.045 | |
| ribonucleoside triphosphate metabolic process | GO:0009199 | 220 | 0.045 | |
| regulation of response to biotic stimulus | GO:0002831 | 38 | 0.045 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.044 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.044 | |
| positive regulation of production of molecular mediator of immune response | GO:0002702 | 45 | 0.044 | |
| regulation of cellular catabolic process | GO:0031329 | 242 | 0.044 | |
| positive t cell selection | GO:0043368 | 23 | 0.044 | |
| striated muscle cell development | GO:0055002 | 125 | 0.044 | |
| cd4 positive alpha beta t cell differentiation | GO:0043367 | 41 | 0.043 | |
| skin development | GO:0043588 | 220 | 0.042 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.042 | |
| cd4 positive alpha beta t cell cytokine production | GO:0035743 | 4 | 0.042 | |
| positive regulation of type i interferon mediated signaling pathway | GO:0060340 | 4 | 0.041 | |
| negative regulation of immune effector process | GO:0002698 | 55 | 0.041 | |
| organonitrogen compound biosynthetic process | GO:1901566 | 192 | 0.041 | |
| myeloid dendritic cell activation | GO:0001773 | 25 | 0.041 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.040 | |
| toll like receptor 9 signaling pathway | GO:0034162 | 6 | 0.040 | |
| hair follicle cell proliferation | GO:0071335 | 3 | 0.039 | |
| negative regulation of nervous system development | GO:0051961 | 156 | 0.039 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.039 | |
| alpha beta t cell proliferation | GO:0046633 | 21 | 0.039 | |
| regulation of nlrp3 inflammasome complex assembly | GO:1900225 | 4 | 0.039 | |
| myeloid dendritic cell differentiation | GO:0043011 | 16 | 0.039 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.039 | |
| negative regulation of viral entry into host cell | GO:0046597 | 10 | 0.038 | |
| regulation of organelle organization | GO:0033043 | 289 | 0.037 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.037 | |
| negative regulation of interferon beta production | GO:0032688 | 3 | 0.036 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.036 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.036 | |
| immunoglobulin production | GO:0002377 | 73 | 0.036 | |
| negative regulation of viral transcription | GO:0032897 | 3 | 0.035 | |
| regulation of tumor necrosis factor production | GO:0032680 | 49 | 0.035 | |
| negative regulation of t cell differentiation | GO:0045581 | 23 | 0.035 | |
| regulation of cd8 positive alpha beta t cell proliferation | GO:2000564 | 1 | 0.035 | |
| regulation of toll like receptor 9 signaling pathway | GO:0034163 | 3 | 0.035 | |
| ribonucleotide metabolic process | GO:0009259 | 291 | 0.035 | |
| alpha beta t cell activation involved in immune response | GO:0002287 | 31 | 0.034 | |
| glycoprotein metabolic process | GO:0009100 | 116 | 0.034 | |
| positive regulation of cytokine production involved in immune response | GO:0002720 | 19 | 0.034 | |
| muscle cell development | GO:0055001 | 133 | 0.034 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.034 | |
| glycosylation | GO:0070085 | 62 | 0.033 | |
| regulation of viral induced cytoplasmic pattern recognition receptor signaling pathway | GO:0039531 | 2 | 0.033 | |
| regulation of hormone levels | GO:0010817 | 211 | 0.033 | |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.032 | |
| lymphocyte activation involved in immune response | GO:0002285 | 93 | 0.032 | |
| positive regulation of lymphocyte activation | GO:0051251 | 140 | 0.032 | |
| defense response to bacterium | GO:0042742 | 119 | 0.032 | |
| positive regulation of myelination | GO:0031643 | 5 | 0.032 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.031 | |
| muscle tissue development | GO:0060537 | 308 | 0.031 | |
| negative regulation of interferon beta biosynthetic process | GO:0045358 | 1 | 0.031 | |
| cellular response to interferon gamma | GO:0071346 | 25 | 0.031 | |
| type 2 immune response | GO:0042092 | 23 | 0.031 | |
| schwann cell proliferation | GO:0014010 | 2 | 0.031 | |
| organophosphate biosynthetic process | GO:0090407 | 122 | 0.030 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.030 | |
| zygote asymmetric cell division | GO:0010070 | 2 | 0.030 | |
| activation of immune response | GO:0002253 | 138 | 0.030 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.030 | |
| positive regulation of jnk cascade | GO:0046330 | 46 | 0.030 | |
| regulation of viral transcription | GO:0046782 | 3 | 0.030 | |
| negative regulation of toll like receptor signaling pathway | GO:0034122 | 14 | 0.030 | |
| regulation of protein transport | GO:0051223 | 163 | 0.030 | |
| regulation of interferon gamma production | GO:0032649 | 57 | 0.030 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.029 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.029 | |
| positive regulation of toll like receptor 9 signaling pathway | GO:0034165 | 2 | 0.029 | |
| stem cell development | GO:0048864 | 219 | 0.029 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.029 | |
| positive regulation of cell activation | GO:0050867 | 158 | 0.028 | |
| t cell activation involved in immune response | GO:0002286 | 43 | 0.028 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.028 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.028 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.028 | |
| posttranscriptional gene silencing | GO:0016441 | 10 | 0.027 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.027 | |
| ear development | GO:0043583 | 200 | 0.026 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.026 | |
| positive regulation of viral entry into host cell | GO:0046598 | 3 | 0.026 | |
| regulation of purine nucleotide catabolic process | GO:0033121 | 122 | 0.026 | |
| t helper 17 cell differentiation | GO:0072539 | 7 | 0.026 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.026 | |
| response to type i interferon | GO:0034340 | 12 | 0.026 | |
| hair follicle morphogenesis | GO:0031069 | 29 | 0.026 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.026 | |
| positive regulation of leukocyte differentiation | GO:1902107 | 86 | 0.026 | |
| regulation of t helper 2 cell cytokine production | GO:2000551 | 3 | 0.026 | |
| regulation of cell migration | GO:0030334 | 219 | 0.026 | |
| cd4 positive alpha beta t cell lineage commitment | GO:0043373 | 6 | 0.026 | |
| hair follicle development | GO:0001942 | 85 | 0.026 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.026 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.025 | |
| regulation of immunoglobulin production | GO:0002637 | 42 | 0.025 | |
| sequestering of metal ion | GO:0051238 | 19 | 0.025 | |
| necrotic cell death | GO:0070265 | 30 | 0.025 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.025 | |
| nucleocytoplasmic transport | GO:0006913 | 139 | 0.025 | |
| regulation of defense response to bacterium | GO:1900424 | 3 | 0.025 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.025 | |
| positive regulation of lymphocyte mediated immunity | GO:0002708 | 62 | 0.025 | |
| interferon beta biosynthetic process | GO:0045350 | 4 | 0.025 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.025 | |
| regulation of nucleotide metabolic process | GO:0006140 | 169 | 0.024 | |
| cd4 positive alpha beta t cell activation | GO:0035710 | 45 | 0.024 | |
| protein acylation | GO:0043543 | 64 | 0.024 | |
| lipid localization | GO:0010876 | 126 | 0.024 | |
| guanosine containing compound catabolic process | GO:1901069 | 144 | 0.024 | |
| microtubule based process | GO:0007017 | 236 | 0.024 | |
| positive regulation of actin nucleation | GO:0051127 | 3 | 0.024 | |
| modification dependent macromolecule catabolic process | GO:0043632 | 133 | 0.024 | |
| positive regulation of cellular component biogenesis | GO:0044089 | 94 | 0.023 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.023 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.023 | |
| antimicrobial peptide production | GO:0002775 | 2 | 0.023 | |
| macromolecule glycosylation | GO:0043413 | 55 | 0.023 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.023 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.023 | |
| regulation of tumor necrosis factor superfamily cytokine production | GO:1903555 | 50 | 0.023 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.023 | |
| regulation of sequence specific dna binding transcription factor activity | GO:0051090 | 106 | 0.023 | |
| olfactory bulb interneuron differentiation | GO:0021889 | 12 | 0.023 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.023 | |
| protein glycosylation | GO:0006486 | 55 | 0.023 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.023 | |
| regulation of neutrophil mediated killing of gram negative bacterium | GO:0070951 | 1 | 0.022 | |
| organelle assembly | GO:0070925 | 177 | 0.022 | |
| positive regulation of gtpase activity | GO:0043547 | 85 | 0.022 | |
| pallium development | GO:0021543 | 120 | 0.022 | |
| regulation of intracellular transport | GO:0032386 | 159 | 0.022 | |
| microtubule cytoskeleton organization | GO:0000226 | 157 | 0.022 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.022 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.022 | |
| action potential | GO:0001508 | 78 | 0.021 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.021 | |
| telencephalon development | GO:0021537 | 186 | 0.021 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 40 | 0.021 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.021 | |
| negative regulation of defense response to virus | GO:0050687 | 6 | 0.021 | |
| positive regulation of t helper 2 cell cytokine production | GO:2000553 | 3 | 0.021 | |
| regulation of purine nucleotide metabolic process | GO:1900542 | 169 | 0.021 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.021 | |
| regulation of cell killing | GO:0031341 | 40 | 0.021 | |
| positive regulation of t cell activation | GO:0050870 | 101 | 0.021 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.021 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.021 | |
| intracellular protein transport | GO:0006886 | 204 | 0.020 | |
| b cell activation involved in immune response | GO:0002312 | 50 | 0.020 | |
| purine containing compound biosynthetic process | GO:0072522 | 70 | 0.020 | |
| gtp catabolic process | GO:0006184 | 143 | 0.020 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.020 | |
| negative regulation of rig i signaling pathway | GO:0039536 | 2 | 0.020 | |
| positive regulation of nucleotide catabolic process | GO:0030813 | 88 | 0.020 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.020 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.020 | |
| regulation of protein localization | GO:0032880 | 231 | 0.020 | |
| posttranscriptional gene silencing by rna | GO:0035194 | 10 | 0.020 | |
| regulation of rho gtpase activity | GO:0032319 | 58 | 0.020 | |
| lipopolysaccharide mediated signaling pathway | GO:0031663 | 25 | 0.020 | |
| cd4 positive or cd8 positive alpha beta t cell lineage commitment | GO:0043369 | 8 | 0.020 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.020 | |
| interferon gamma production | GO:0032609 | 67 | 0.020 | |
| regulation of production of molecular mediator of immune response | GO:0002700 | 65 | 0.020 | |
| limb morphogenesis | GO:0035108 | 149 | 0.019 | |
| proteolysis involved in cellular protein catabolic process | GO:0051603 | 147 | 0.019 | |
| negative regulation of cell cycle process | GO:0010948 | 69 | 0.019 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.019 | |
| regulation of interleukin 8 production | GO:0032677 | 3 | 0.019 | |
| interleukin 6 production | GO:0032635 | 58 | 0.019 | |
| single organism nuclear import | GO:1902593 | 95 | 0.019 | |
| regulation of cellular component biogenesis | GO:0044087 | 181 | 0.019 | |
| negative regulation of defense response to virus by host | GO:0050689 | 1 | 0.019 | |
| t helper 2 cell cytokine production | GO:0035745 | 4 | 0.019 | |
| mitotic cell cycle | GO:0000278 | 195 | 0.019 | |
| gtp metabolic process | GO:0046039 | 144 | 0.019 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.019 | |
| hair cycle | GO:0042633 | 90 | 0.019 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.019 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.019 | |
| methylation | GO:0032259 | 134 | 0.019 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.019 | |
| epidermis development | GO:0008544 | 187 | 0.019 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.019 | |
| regulation of cd8 positive alpha beta t cell activation | GO:2001185 | 3 | 0.019 | |
| regulation of protein secretion | GO:0050708 | 82 | 0.018 | |
| positive regulation of gtp catabolic process | GO:0033126 | 85 | 0.018 | |
| antibacterial peptide production | GO:0002778 | 2 | 0.018 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.018 | |
| positive regulation of myotube differentiation | GO:0010831 | 24 | 0.018 | |
| lung development | GO:0030324 | 164 | 0.018 | |
| regulation of type i interferon mediated signaling pathway | GO:0060338 | 7 | 0.018 | |
| ribonucleotide catabolic process | GO:0009261 | 208 | 0.018 | |
| protein methylation | GO:0006479 | 81 | 0.018 | |
| molting cycle | GO:0042303 | 90 | 0.018 | |
| syncytium formation | GO:0006949 | 43 | 0.018 | |
| gland development | GO:0048732 | 330 | 0.018 | |
| syncytium formation by plasma membrane fusion | GO:0000768 | 42 | 0.018 | |
| positive regulation of purine nucleotide metabolic process | GO:1900544 | 114 | 0.018 | |
| cell fate commitment | GO:0045165 | 210 | 0.018 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.018 | |
| positive regulation of cellular catabolic process | GO:0031331 | 148 | 0.018 | |
| positive regulation of response to biotic stimulus | GO:0002833 | 15 | 0.018 | |
| production of small rna involved in gene silencing by rna | GO:0070918 | 6 | 0.018 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.018 | |
| organism emergence from protective structure | GO:0071684 | 4 | 0.018 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.018 | |
| regulation of cytokine secretion | GO:0050707 | 61 | 0.018 | |
| dna damage response signal transduction by p53 class mediator | GO:0030330 | 19 | 0.017 | |
| chromatin modification | GO:0016568 | 187 | 0.017 | |
| protein import | GO:0017038 | 101 | 0.017 | |
| neuronal action potential | GO:0019228 | 54 | 0.017 | |
| regulation of t cell differentiation | GO:0045580 | 83 | 0.017 | |
| mesenchymal cell development | GO:0014031 | 93 | 0.017 | |
| regulation of interleukin 2 secretion | GO:1900040 | 6 | 0.017 | |
| negative regulation of secretion by cell | GO:1903531 | 54 | 0.017 | |
| hatching | GO:0035188 | 4 | 0.017 | |
| regulation of defense response to fungus | GO:1900150 | 1 | 0.017 | |
| positive regulation of smooth muscle cell migration | GO:0014911 | 4 | 0.017 | |
| cerebral cortex development | GO:0021987 | 86 | 0.017 | |
| positive regulation of leukocyte proliferation | GO:0070665 | 73 | 0.017 | |
| pre mirna processing | GO:0031054 | 3 | 0.017 | |
| dendritic cell differentiation | GO:0097028 | 26 | 0.017 | |
| morphogenesis of a branching structure | GO:0001763 | 203 | 0.017 | |
| regulation of synaptic growth at neuromuscular junction | GO:0008582 | 4 | 0.016 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.016 | |
| regulation of interferon beta biosynthetic process | GO:0045357 | 4 | 0.016 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.016 | |
| positive regulation of multi organism process | GO:0043902 | 26 | 0.016 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.016 | |
| rho protein signal transduction | GO:0007266 | 32 | 0.016 | |
| antimicrobial peptide biosynthetic process | GO:0002777 | 2 | 0.016 | |
| regulation of osteoblast differentiation | GO:0045667 | 67 | 0.015 | |
| regulation of homeostatic process | GO:0032844 | 182 | 0.015 | |
| translation | GO:0006412 | 93 | 0.015 | |
| positive regulation of stress activated mapk cascade | GO:0032874 | 48 | 0.015 | |
| interleukin 2 secretion | GO:0070970 | 7 | 0.015 | |
| regulation of myotube differentiation | GO:0010830 | 62 | 0.015 | |
| positive regulation of interleukin 12 production | GO:0032735 | 21 | 0.015 | |
| positive regulation of secretion | GO:0051047 | 130 | 0.015 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.015 | |
| positive regulation of interleukin 8 secretion | GO:2000484 | 1 | 0.015 | |
| myotube cell development | GO:0014904 | 60 | 0.015 | |
| regulation of cytokine production involved in immune response | GO:0002718 | 26 | 0.015 | |
| alpha beta t cell lineage commitment | GO:0002363 | 7 | 0.015 | |
| production of mirnas involved in gene silencing by mirna | GO:0035196 | 6 | 0.015 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.015 | |
| protein import into nucleus | GO:0006606 | 95 | 0.015 | |
| forebrain development | GO:0030900 | 302 | 0.015 | |
| appendage development | GO:0048736 | 166 | 0.015 | |
| connective tissue development | GO:0061448 | 179 | 0.015 | |
| myd88 independent toll like receptor signaling pathway | GO:0002756 | 3 | 0.015 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.015 | |
| stress activated mapk cascade | GO:0051403 | 80 | 0.015 | |
| response to radiation | GO:0009314 | 165 | 0.015 | |
| nerve development | GO:0021675 | 67 | 0.014 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.014 | |
| skeletal system development | GO:0001501 | 356 | 0.014 | |
| regulation of glial cell differentiation | GO:0045685 | 41 | 0.014 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.014 | |
| protein processing | GO:0016485 | 163 | 0.014 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.014 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.014 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.014 | |
| glycoprotein biosynthetic process | GO:0009101 | 89 | 0.014 | |
| regulation of antimicrobial humoral response | GO:0002759 | 3 | 0.014 | |
| regulation of alpha beta t cell proliferation | GO:0046640 | 18 | 0.014 | |
| positive regulation of antimicrobial peptide biosynthetic process | GO:0002807 | 1 | 0.014 | |
| regulation of lymphocyte apoptotic process | GO:0070228 | 41 | 0.014 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.014 | |
| cellular component assembly involved in morphogenesis | GO:0010927 | 139 | 0.014 | |
| limb development | GO:0060173 | 166 | 0.014 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.014 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.014 | |
| protein localization to organelle | GO:0033365 | 185 | 0.014 | |
| proteasome mediated ubiquitin dependent protein catabolic process | GO:0043161 | 88 | 0.014 | |
| interleukin 8 production | GO:0032637 | 4 | 0.014 | |
| regulation of cell motility | GO:2000145 | 236 | 0.014 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.014 | |
| cellular response to organic cyclic compound | GO:0071407 | 87 | 0.014 | |
| regulation of nucleoside metabolic process | GO:0009118 | 130 | 0.014 | |
| chemokine production | GO:0032602 | 34 | 0.014 | |
| response to phenylpropanoid | GO:0080184 | 22 | 0.014 | |
| peptidyl lysine methylation | GO:0018022 | 29 | 0.014 | |
| regulation of regulatory t cell differentiation | GO:0045589 | 7 | 0.014 | |
| myoblast differentiation | GO:0045445 | 52 | 0.013 | |
| positive regulation of purine nucleotide catabolic process | GO:0033123 | 88 | 0.013 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.013 | |
| regulation of myd88 independent toll like receptor signaling pathway | GO:0034127 | 1 | 0.013 | |
| phosphatidylinositol 3 kinase signaling | GO:0014065 | 36 | 0.013 | |
| angiogenesis | GO:0001525 | 201 | 0.013 | |
| cytoplasmic pattern recognition receptor signaling pathway | GO:0002753 | 10 | 0.013 | |
| positive regulation of nucleotide metabolic process | GO:0045981 | 114 | 0.013 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.013 | |
| multicellular organism growth | GO:0035264 | 161 | 0.013 | |
| cation homeostasis | GO:0055080 | 212 | 0.013 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.013 | |
| gene silencing by rna | GO:0031047 | 19 | 0.013 | |
| pyrimidine containing compound catabolic process | GO:0072529 | 3 | 0.013 | |
| myotube differentiation | GO:0014902 | 105 | 0.013 | |
| inflammatory response | GO:0006954 | 244 | 0.013 | |
| purine nucleoside monophosphate metabolic process | GO:0009126 | 81 | 0.013 | |
| peptide transport | GO:0015833 | 133 | 0.013 | |
| mammary gland morphogenesis | GO:0060443 | 54 | 0.013 | |
| amine metabolic process | GO:0009308 | 45 | 0.013 | |
| myeloid cell homeostasis | GO:0002262 | 114 | 0.013 | |
| negative regulation of cell cycle phase transition | GO:1901988 | 48 | 0.013 | |
| ganglion development | GO:0061548 | 13 | 0.013 | |
| regulation of nucleotide catabolic process | GO:0030811 | 122 | 0.013 | |
| mammary gland epithelium development | GO:0061180 | 65 | 0.013 | |
| positive regulation of nucleoside metabolic process | GO:0045979 | 91 | 0.013 | |
| t cell proliferation | GO:0042098 | 120 | 0.013 | |
| negative regulation of sequence specific dna binding transcription factor activity | GO:0043433 | 40 | 0.013 | |
| divalent metal ion transport | GO:0070838 | 172 | 0.013 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.013 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.013 | |
| programmed necrotic cell death | GO:0097300 | 28 | 0.013 | |
| purine ribonucleoside monophosphate metabolic process | GO:0009167 | 80 | 0.013 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.013 | |
| regulation of stress activated mapk cascade | GO:0032872 | 69 | 0.013 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.013 | |
| regulation of cd4 positive alpha beta t cell activation | GO:2000514 | 24 | 0.012 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.012 | |
| dephosphorylation | GO:0016311 | 129 | 0.012 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.012 | |
